Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration
Longitudinal analysis
Brain
Neurosciences. Biological psychiatry. Neuropsychiatry
Neuroimaging
Alzheimer's disease
Magnetic Resonance Imaging
Article
03 medical and health sciences
Cross-Sectional Studies
0302 clinical medicine
Brain age estimation
Alzheimer Disease
Multimodal imaging
Machine learning
Disease Progression
Humans
Cognitive Dysfunction
Biomarkers
RC321-571
DOI:
10.1016/j.neuroimage.2022.119621
Publication Date:
2022-09-09T07:16:22Z
AUTHORS (9)
ABSTRACT
ABSTRACTNeuroimaging-based brain-age estimation via machine learning has emerged as an important new approach for studying brain aging. The difference between one’s estimated brain age and chronological age, the brain age gap (BAG), has been proposed as an Alzheimer’s Disease (AD) biomarker. However, most past studies on the BAG have been cross-sectional. Identifying how an individual’s BAG temporal pattern changes over time would enable improved prediction of clinical outcome based on neurophysiological changes and better understanding of AD progression. To fill this gap, our study conducted predictive modeling using large neuroimaging data with up to 8 years of follow-up to examine the temporal patterns of the BAG’s trajectory and how it varies by subject-level characteristics and disease status. To the best of our knowledge, this is the first effort to take a longitudinal approach to investigate the pattern and rate of change in BAG over time in individuals who progress from mild cognitive impairment (MCI) to clinical AD. Combining multimodal imaging data in a support vector regression model to estimate brain age yielded improved performance than single modality. Multilevel modeling results showed the BAG followed a linear increasing trajectory with a significantly faster rate in individuals with MCI who progressed to AD compared to cognitively normal or MCI individuals who did not progress. The dynamic changes in the BAG during AD progression were further moderated by gender and APOε4 carriership. Findings demonstrate the BAG as a potential biomarker for understanding individual specific temporal patterns related to AD progression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (95)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....